Related Experiment Videos
Peripatetic intravenous service for metabolic bone disease: case study in patient centred-care for new NHS
Michael Davie1, Paula Jeffreson, Teresa Jones
1The Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust, Oswestry, Shropshire, UK. mike.davie@rjah.nhs.uk
Insights
A new peripatetic intravenous service (PIVS) for osteoporosis care is cost-neutral, improves patient convenience, and reduces the NHS carbon footprint. This community-based model offers significant mileage and CO(2) savings compared to traditional hospital visits.
Area of Science:
- Health Services Research
- Osteoporosis Management
- Sustainable Healthcare
Background:
- Delivering specialist osteoporosis care often involves significant patient travel to hospital.
- Conventional treatment models can contribute to a substantial carbon footprint and incur patient costs.
- There is a need for accessible, cost-effective, and environmentally friendly healthcare delivery models.
Purpose of the Study:
- To develop and evaluate a 'close to patient' peripatetic intravenous service (PIVS) for osteoporosis care.
- To assess the cost-neutrality and feasibility of PIVS in a community setting.
- To determine the impact of PIVS on patient experience, travel, and carbon footprint.
Main Methods:
- A peripatetic intravenous service (PIVS) for bisphosphonate treatment was modelled using UK NHS costings.
- The model was field-tested for one year, comparing patient mileage and travel methods to current hospital-based practice.
- Patient satisfaction, cost per patient, and CO(2) emissions were the primary outcome measures.
Main Results:
- PIVS was found to be cost-neutral, with annual costs between £557-£622 per patient.
- 98% of patients rated the PIVS as more convenient than hospital attendance.
- The service significantly reduced hospital transport, saving 2000 miles monthly and 6072 kg CO(2) annually, with no medical emergencies in 410 infusions.
Conclusions:
- Peripatetic intravenous service (PIVS) is a viable, cost-neutral alternative to conventional osteoporosis care.
- PIVS enhances patient experience and substantially reduces the NHS carbon footprint and transport costs.
- The suitability of PIVS may vary by drug type and geographic area (e.g., rural vs. urban).
Objective:
To develop a 'close to patient' peripatetic intravenous service (PIVS) for delivery of specialist osteoporosis care in a community setting without increasing cost and with a reduced carbon footprint.
Research Design And Methods:
Cost and feasibility of a PIVS for intravenous (i.v.) bisphosphonate treatment were modelled using UK National Health Service costings and then tested in the field for 1 year. Average patient mileage to peripatetic sites was compared with mileage travelled if treated at the base hospital (current practice). The method of travel to hospital (current practice) or peripatetic sites (new study) was ascertained together with patients' preference for the new or the current system. Peripatetic sites were researched and those with suitable facilities selected. Data for fuel consumption were based on a usage of 1 litre per 14.5 km.
Main Outcome Measures:
The main outcome measure was cost comparison between hospital and peripatetic services. Others included patient satisfaction, miles saved, method of travel to the clinic and changes in CO(2) emissions.
Results:
Cost per patient, including drugs, lies between pound557 and pound622 annually for 1000 and 500 patients, respectively which is cost-neutral compared with hospital attendance. PIVS was rated more convenient by 98% of patients. Hospital transport was significantly reduced and the total monthly saving of 2000 miles has reduced CO(2) emission by 6072 kg p.a. No medical emergency occurred in 410 infusions.
Conclusions:
PIVS is cost neutral compared with a conventional service, leads to a better patient experience, a significant cutback in hospital transport costs and a reduction of the NHS carbon footprint. However not all drugs may be suitable for this service: the area served was rural with large distances and poor public transport and mileage savings may not accrue in urban areas. Insurance was not included in the calculation of costs.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Peritoneal Dialysis III: Nursing Management